Compare
Boston Scientific vs Medtronic (BSX vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Boston Scientific (BSX) returned -56.8% and Medtronic (MDT) +12.6%; so far this year the figures are -55.2% and +6.0%.
Medtronic is the larger company by market value, about 2.1 times the size of Boston Scientific.
On trailing earnings, BSX trades at 18.1 times and MDT at 25.0 times.
Revenue grew +8.9% at BSX and +9.8% at MDT over the last year.
BSX pays no dividend. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| BSX | MDT | |
|---|---|---|
| Price | $42.75 | $101.80 |
| 1-day | -4.23% | -2.90% |
| YTD | -55.17% | +5.98% |
| 1 year | -56.77% | +12.61% |
| 3 years | -17.25% | +43.68% |
| Market cap | $62.0B | $130.2B |
| P/E | 18.1 | 25.0 |
| P/S | 2.94 | 3.47 |
| P/B | 2.42 | 2.59 |
| Revenue growth | +8.90% | +9.80% |
| EPS growth | +26.20% | +12.10% |
| Gross margin % | 69.1 | 65.0 |
| Net margin % | 16.6 | 13.9 |
| ROE % | 13.7 | 10.4 |
| Debt / equity | 0.47 | 0.56 |
| FCF yield % | 5.4 | 4.7 |
| Dividend yield % | — | 2.81 |
| Beta | 0.22 | 0.14 |
| RSI (14) | 44.9 | 63.8 |
| Technical rating |